| Logo | Name | Σ | Employees |
|---|---|---|---|
 |  Lantern Pharma Inc. (Nasdaq: LTRN) Leveraging Artificial Intelligence to Rescue and Develop Cancer Therapies Lantern Pharma, Inc. is a clinical stage pharmaceutical company developing new classes of precision cancer drugs with novel mechanisms of action, and also rescuing or revitalizing abandoned or failed cancer drugs using machine learning techniques, genomic data and precision oncology trials. Lantern Pharma recognizes that the high cost and low success rates in oncology drug development largely stem from the inability to appropriately stratify patient populations prior to enrollment, and also from the inability to fully elucidate mechanisms of action that can suggest potent combinations. Our approach which leverages our RADR … Type: | 1 | 26 |
 | MedUniverse Bridging the information gap between pharma and healthcare professionals using the power of interactive patient cases. MedUniverse helps the Life Sciences Industry to drive increased HCP engagement and results through the power of interactive patient case studies. The company has more than 15 global pharmaceutical companies as customers, within more than 20 therapeutic areas in 40+ markets worldwide. The vision is to become the industry standard platform for engagement and dialogue between HCPs and life sciences companies, ultimately improving patient outcomes. Pharmaceutical marketing, medical education, MedEd, Sales Forces Effectiveness, Multi channel marketing, digital, patient case, HCP Engagement, Healthcare professional engagement, … Type: | 4 | 16 |
 | Sequence Bio Discovering the true signals of disease to power life-changing medicines. 90% of drug candidates fail, delaying help for those in need. We’re on a mission to change that with better, faster drug target discovery powered by the Newfoundland founder effect. Biotechnology and Drug Discovery Type: | 4 | 19 |
 | Coloursmith Labs Inc. Advancing Vision Care with Next-Generation Light-Filtering Technology Coloursmith is pioneering the future of vision care with advanced light-filtering technology that elevates contact lenses to new levels of functionality and performance. Our patented platform enables the development of lenses that not only enhance visual comfort but also support eye health and lifestyle needs, meeting the growing demand for specialized vision solutions. Rooted in cutting-edge R&D and driven by a commitment to excellence, Coloursmith partners with leading industry players to bring innovative lens solutions to market. We focus on creating value through technology that empowers vision care companies to differentiate their products … Type: | 0 | 10 |
 | Dalan Animal Health, Inc. Dalan's novel platform technology has introduced the world's first-ever honeybee vaccine, marking a pivotal milestone for the industry. Our mission is to safeguard the planet’s most underserved animal species, ensuring their continued well-being for global food security and the overall health of our planet. Type: | 1 | 29 |
 | Nicoya Our mission is to improve human life by helping scientists succeed. Nicoya is a Canadian biotechnology company dedicated to improving human life by helping scientists succeed. Established in 2012, Nicoya was founded by Ryan Denomme in his relentless pursuit to use nanotechnology to increase the affordability and ease of use of scientific instruments. Within 10 years, Nicoya has grown to a team of 100+ employees who have extensive experience working at the forefront of nanotechnology and biotechnology sectors. Nicoya develops innovative and accessible biosensor technology for in-depth characterization of biomolecular interactions. Alto, the world’s first digital high-throughput benchtop SPR instrument, … Type: | 3 | 118 |
 | Pear Bio Patient-centered cancer precision medicine Pear Bio analyzes patient tumor samples and data with a proprietary computational biology platform to deconvolute complex cancer biology and drive patient-centric functional precision medicine and drug discovery. Our ultimate goal is to optimally allocate approved treatments to cancer patients who will benefit from them, while creating novel therapies that are purpose-designed for patients who don't respond to available treatments. The platform uses microphysiological systems and 3D computer vision to measure cancer progression over time. Pear Bio cultures patient tumor samples with matched blood into 3D immune-microtumors to test potential treatment options and combinations ex vivo. … Type: | 3 | 35 |
 | BioCorteX We believe that everyone - irrespective of who they are or where they live - deserve medications that work We believe that everyone - irrespective of who they are or where they live - deserve medications that work Type: | 2 | 15 |
 |  MEDIBIOFARMA SL To make disease-modifying treatments available to patients with serious or life-threatening conditions Medibiofarma S.L is a clinical-stage biotechnology company founded in 2016 by a group of professionals with extensive experience in Drug Discovery in the pharmaceutical industry. We aim to generate innovative and high quality research programs based on the modulation of clinically validated therapeutic targets for the treatment of cancer and non-cancer diseases. Medicinal Chemistry, in vitro Pharmacology, Drug Discovery and Development, IP generation, IBD (Colitis, Crohn), Oncology, CNS, and Synaptopathies Type: | 0 | 9 |
 | Modus Therapeutics Holding AB We develop sevuparin to help patients with severe conditions and high unmet medical need. Modus Therapeutics is a Swedish biotech company developing sevuparin for diseases with high unmet medical need. The Company’s near-term focus is to develop sevuparin for patients with sepsis/septic shock, a severe and often fatal condition. Sepsis, Systemic inflammation, Heparinoids, Pharmaceutical development, and Pharmaceutical research Type: | 0 | 4 |
 | HOOKIPA Pharma Inc. Supercharging Immunotherapy At HOOKIPA, we envision a world in which cancers and infectious diseases can be chronically managed or eradicated. HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical-stage biopharmaceutical company advancing the field of immunotherapy through the development of new immunotherapies based on our proprietary arenavirus platform, which is designed to mobilize and amplify targeted T cells and thereby fight or prevent serious disease. Our pipeline includes wholly owned investigational arenaviral immunotherapies targeting HPV16+ cancers, prostate cancer, KRAS-mutated cancers (including colorectal, pancreatic and lung), and other undisclosed programs. In addition, HOOKIPA aims to develop functional cures for HBV and HIV … Type: | 4 | 112 |
 | Acticor Biotech To treat the acute phase of ischemic stroke ! Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of an innovative therapeutic strategy for a safe and effective emergency treatment of ischemic strokes which account for 80% of all strokes. Acticor Biotech’s project stems from the sheer need for new therapeutic options to manage stroke. According to the World Health Organization, 15 million people suffer stroke worldwide each year. Of these, 5 million die and another 5 million are permanently disabled. Stroke is the third cause of death in the … Type: | 14 | 23 |
 | lifeina Creators of the world's smallest fridge, designed to keep your medication at a constant temperature wherever you may go. Our future is one in which the lives of medication users are not dictated by their health. A future where you have the freedom to take control by using the right tools. ___ Without flawless execution, ingenious ideas might as well remain dreams. We honour our reputation and strive to be industry leaders. In doing so, we keep our small team flexible enough to listen and respond to your needs directly. So, when you speak to one of us, you’re speaking … Type: | 5 | 7 |
 |  Insight Biosolutions Your safety passport for cosmetic ingredients & drug candidates Your partner for toxicological risk assessment requests Using our digital solutions increases the product safety and reduces the product development cost up by 30%. Insight Biosolutions (IBS) with his expert network has developed specialized platforms for in vitro and in silico services. IBS develops digital tools and services for the cosmetics and pharmaceutical industries. Computational Toxicology, in vitro toxicology , Safety assessment, Drug Discovery, Molecular Modeling, Computational Chemistry, CPSR, Pre Clinical screening, ADME, and PBPK Type: | 3 | 4 |
 | Origem Sustainable Sourcing Fulfill companies’ sourcing ambitions by bringing them closer to sustainable solutions Origem guides your company implementing a sustainable sourcing strategy. Today, having a sustainable and traceable sourcing strategy is both a strength and a competitive advantage. Tomorrow, it will be the norm: requirements related to traceability and social and environmental production conditions of raw materials will be as important as quality and prices. Origem wants to embody the companies’ shift towards models that will transcend Human and Nature’s strength At Origem ... • We look for exemplary raw materials; whether mineral, plant or animal • We identify and connect the … Type: | 9 | 4 |
 | Manzalab DIGITAL EXPERIENCING PIONEER Manzalab Group is a digital experiences designer. Since 2010, we use neuroscience research scientific rigor and technological developments to serve all sorts of creativity. With offices in Paris, Aix-en-Provence and Singapore, our ecosystem comprises six entities, six different but complementary excellence centers: Manzalab, Manzavision, Akenomy, Perfect Industry, CyberZen and Longue-Vue. Together, we create new digital experiences covering several different areas such as: training, communication, design, industry, cyber-security and entertainment. At the forefront of Collaborative VR, we design our experiences for PCs, tablets and mobile phones as well as for virtual and augmented reality environments. Our skills The … Type: | 18 | 25 |
 | InnaVirVax InnaVirVax is a French privately-owned biopharmaceutical company dedicated to the development of a cutting edge discovery in the field of therapy/prevention and prognostic of AIDS and HIV infection, other infectious diseases, and cancer therapies. InnaVirVax is developing product candidates resulting from a beakthrough discovery, made at Inserm, the French Medical research council, the AP-HP, the largest hospital in Europe, and University Pierre et Marie Curie in Paris. Based on a new paradigm (i.e. the understanding of the mechanism responsible for the decline of the CD4+ T lymphocytes (CD4) in HIV-infected patients), the products currently developed by InnaVirVax will allow the … Type: | 0 | 0 |
 | DeepLife AI for digital twin of cells DeepLife is an early stage startup founded in 2019 by Jonathan Baptista and Jean-Baptiste Morlot, backed by international investors, developing the first SaaS platform for Digital Twin of cells. While we are able to design and build incredibly complex mechanical engines, engineering biological systems, such as cells, remains a challenge. However, recent technological improvements, notably in biochemistry, recently enabled the construction of databases with millions of quantitative cell activity measures, covering multiple diseases. The DeepLife team develops a SaaS platform combining state-of-the-art deep learning algorithms on multi-omics sequencing data, public and private cell atlases, … Type: | 21 | 28 |
 | Unibiome (Peer To Peer Probiotics) Unibiome develops fermentative microbes that have been engineered to produce vitamins and other healthy compounds and designed to be used with any fermentation-based food to increase its nutritional value. We believe that re-purposing the food microbiome is a game-changing approach to feeding 9 billion people by 2050. Biotechnology, Synthetic Biology, Design, Microbiology, and Food Fortification Type: | 0 | 1 |
 | CITRAGE, Stratégies nutritionnelles innovantes dédiées à la santé des séniors Citrage is a research and development company in the field of health nutrition. It develops in partnership with the University of Paris Descartes food supplements and oral nutritional supplements for people over 50. The two main products are made up of 100% Citrulline, an unprotic amino acid, having a direct action on muscle protein synthesis, thus optimizing the use of other amino acids and allowing better maintenance of the muscles. - Myocit is a dietary supplement to preserve muscle capital during aging, it is intended for young seniors in prevention of muscle -linked muscle -related (generating loss of tone, dynamism, … Type: | 0 | 5 |
 | Theranexus Theranexus is a biopharmaceutical company that develops drug candidates to be used in the treatment of central nervous. Theranexus is an innovative biopharmaceutical company that spun off from the French Alternative Energies and Atomic Energy Commission (CEA). It specializes in the treatment of rare central nervous system disorders and is a pioneer in the development of drug candidates targeting both neurons and glial cells. Theranexus has a unique advanced therapy candidate identification and characterization platform focused on rare neurological disorders and an initial drug candidate in clinical development for Batten disease. Type: | 12 | 14 |
 | Cyrebro Neurosignals CAPTURE EMOTIONAL AND COGNITIVE INSIGHTS FROM BRAIN DYNAMICS myBrain Tech devient CYREBRO NEUROSIGNALS La plateforme de myBrain Tech aide les industries à simplifier l'interprétation de la dynamique du cerveau et à extraire des informations instructives pour mieux comprendre l'impact de leur produit ou service sur le cerveau de leurs utilisateurs. Notre équipe de neuroscientifiques et de data scientists développe des algorithmes et des tableaux de bord automatisés pour analyser et interpréter les données EEG et comportementales des humains dans un contexte réel, et créer un modèle d'IA stratégique. myBrain Tech's platform helps industries to simplify the interpretation of brain dynamics … Type: | 30 | 15 |
 |  InVenis Biotherapies Platelet-derived Regenerative Therapy for CNS Disorders InVenis Biotherapies is a biotech compagny, spin-off from academic laboratory U1172 and Taipei Medical University, developping innovative regenerative therapies based on blood platelet. Thanks to the high therapeutic potential of our product, we target the most severe diseases involving cell death, as the amyotrophic lateral sclerosis. Type: | 7 | 2 |
 | MED'INN'Pharma A clinic-ready biotech developing human cell-derived secretome drugs to cure inflammation-related pathologies Med’Inn’Pharma (MIP) is a clinic-ready Biotech company that was founded in 2017 as a spin-off from the French blood bank establishment (EFS) and of the French National Institute of Health (INSERM). MIP is a pioneer in developing a new class disease modifying therapies dedicated to resolve pathologic inflammation in a wide range of degenerative diseases and conditions. Our founders are world leaders in immunology and inflammation-resolution, and have developed a patent protected process to harness bioactive molecules from physiologically conditioned human cells into a stable biologic drug product. … Type: | 5 | 5 |
 | Cellaven Cell culture automation, affordable and easy to use, for R&D labs. Cell culture automation for R&D labs: Affordable, time-saving and easy to use. The Nestor automaton is a plug-and-play device able to culture cells in up to 10 flasks or multiwell plates. It is ultra-compact and portable, with a 2xA4 sheet footprint and a weight below 5 kg. Automate the most time consuming tasks in your cell culture processes, for an investment in the range of any other basic lab equipment (and get a return on your investment within 24 months only). biotechnology, automated cell culture, and 3D cell culture Type: | 11 | 5 |
 | Phost'in Therapeutics Unmask Cancer, Elicit Immune Response Phost’in Therapeutics discovers and develops First-In-Class Glycocalyx Modifiers for selective treatment of cancers and other serious diseases. A new and innovative player in the field of Glyco-Immuno-Oncology, Phost’in Therapeutics develops a class of highly potent anti-cancer NCEs (new chemical entities) targeting a key glycosylation mechanism responsible for suppressing the immune response. Our first generation of Glycosylation inhibitors aims to unblock immune response and down-modulate invasiveness for the treatment of aggressive solid tumors. Glyco Immuno Oncology Type: | 11 | 14 |
 | Newronika S.p.A. Building Brain Computers Building Brain Computers Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normal daily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and … Type: | 2 | 22 |
 | NAOS (Bioderma - Institut Esthederm - Etat Pur) Pioneer of Ecobiology. The company behind BIODERMA, Institut Esthederm and Etat Pur. Made in France products. When he created the first BIODERMA and Institut Esthederm products in 1977, Jean-Noël Thorel, a pharmacist-biologist, paved the way for active cosmetics by integrating biology into cosmetics, with the aim of changing the paradigm. Present today in more than 100 countries, NAOS has chosen a single design and manufacturing site, NAOS Les Laboratoires, in Aix-en-Provence (France), in order to control the quality and unique design of its products. NAOS brands - BIODERMA, Institut Esthederm and Etat Pur - claim a unique approach: ecobiology. A … Type: | 15 | 3,474 |
 | Galmed Pharmaceuticals Ltd. A clinical-stage drug development biopharmaceutical company for liver, metabolic & inflammatory diseases Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases. Our lead compound, AramcholTM, a backbone drug candidate for the treatment of NASH and fibrosis is currently in a Phase 3 registrational study. We are also collaborating with the Hebrew University in the development of Amilo-5MER, a 5 amino acid synthetic peptide. Our corporate headquarters is located in Tel Aviv, Israel. For more information about Galmed, please visit our website at: www.galmedpharma.com Type: | 1 | 11 |
 | AreteMedical Our mission is to improve patient outcomes and healthcare efficiency, starting with chronic respiratory conditions. Chronic respiratory diseases reduce the quality of life of millions worldwide, and are a major cause of death. Health systems are increasingly strained. We believe improved care in the future can only come from more preventative and precision care. We apply advances in digital technologies and medical devices to both improve care and health system efficiency. Type: | 6 | 3 |
 | Longevity.Technology The #1 destination for daily news and insights on the fast-growth longevity market. Just how close is technology that will enable humans to have hyper-extended lifespans? Closer than you think. Our mission is to bring together innovators, researchers, insurers, policy-makers, practitioners and commentators to address the new and fast-growing science and investment category that will shape the future of both the world’s population and the global economy: LONGEVITY Organ replacement, Nanotechnology, Senescence, Genetic engineering, Drug development, Artificial intelligence, Digital health, Man machine integration, and Eldercare | 3 | 12 |
 | Bionova Scientific CDMO Services (Research, Development and cGMP Manufacturing for Biologics) Bionova Scientific is a dynamic, full service, biologics Contract Development and Manufacturing Organization (CDMO) on a mission to deliver the highest quality process development and manufacturing services to biologic drug development companies around the world. Bionova’s renowned scientific expertise and dedication to its customers helps life changing therapies arrive to the market faster and more efficiently. At the heart of Bionova is a team of highly dedicated experts combining strong experience in cGMP biologics manufacturing and process development, with a technology-focused approach and a deep knowledge of the industry. From early … Type: | 1 | 99 |
 | World Bladder Cancer Patient Coalition The global voice of people affected by bladder cancer. World-wide there is estimated to be more than 570,000 people who are newly diagnosed with bladder cancer each year and 165,000 will die from the disease. Yet, until 2018, there was not one single organisation to speak as the global voice for peoples living with bladder cancer. The World Bladder Cancer Patient Coalition is an association bringing together representatives of national bladder cancer organisations. Type: | 1 | 5 |
 | Asia Cancer Forum The organization aims to improve cancer care in Asia, making policy recommendations to realize Universal Health Coverage (UHC) and carrying out interdisciplinary activities to support those living with cancer in local communities. The organization based at the University of Tokyo works to resolve cancer-related medical and social issues. 医療, 保健, がん, Medical, Health, Cancer, アジア, and Asia Type: | 1 | N/A |
 | WORLDSymposium WORLDSymposiumTM is an annual research conference dedicated to lysosomal diseases. W.O.R.L.D. is an acronym that stands for We’re Organizing Research on Lysosomal Diseases. Since its inception as a small group of passionate researchers in 2002, WORLDSymposium has grown to an international research conference that attracts over 1600 participants from more than 50 countries around the globe. Type: | 1 | 4 |
 | Taiho Pharmaceutical Co., Ltd., We strive to improve human health and contribute to a society enriched by smiles Taiho Pharmaceutical, a subsidiary of Otsuka Holdings Co., Ltd., is an R&D-driven specialty pharma focusing on the three fields of oncology, allergy and immunology, and urology. Its corporate philosophy takes the form of a pledge: “We strive to improve human health and contribute to a society enriched by smiles.” In the field of oncology in particular, Taiho Pharmaceutical is known as a leading company in Japan for developing innovative medicines for the treatment of cancer, a reputation that is rapidly expanding through their extensive global R&D … Type: | 1 | 146 |
 | OpenBiome OpenBiome accelerates microbiome science to improve health for all. We partner with leading researchers, clinicians, and innovators to advance and ensure access to novel and affordable microbiome therapeutics. microbiome, fecal transplantation, c. difficile, infectious disease, autoimmune disease, malnutrition, research and development, clinical trials, and global health Type: | 2 | 25 |
 | Rosalind Franklin Institute Changing the way we see life The Rosalind Franklin Institute is a new national institute dedicated to bringing about transformative changes in life science through interdisciplinary research and technology development. The Institute will bring together researchers in life sciences, physical sciences, and engineering, to develop disruptive new technologies designed to tackle major challenges in health and life sciences. The Institute is an independent organisation funded by the UK government through the Engineering and Physical Sciences Research Council (EPSRC) and governed by a joint venture of by ten UK universities, and will have its central hub at the Harwell Campus, delivered … Type: | 8 | 159 |
 | 3P Biopharmaceuticals We are now 3PBIOVIAN! Follow us on our new LinkedIn page, 3PBIOVIAN, to stay updated on all the latest developments and news! 3P Biopharmaceuticals and Biovian join forces to create 3PBIOVIAN, a leading pan-European biologics CDMO. Read more here: www.3pbiovian.com ***** 3PBIOVIAN is a globally operating Contract Development and Manufacturing Organization (CDMO), delivering end-to-end services for biotech and pharma companies. Our service offering includes microbial and mammalian protein expression platforms, viral vector production for adenoviruses and adeno-associated viruses, cell therapy, and plasmid DNA production. Additionally, we provide fill and finish services for recombinant proteins and viral vectors. With a combined … Type: | 4 | 197 |
 | ScienceOne AI-Powered Professional Platform for Life Sciences AI-Powered Professional Platform for Life Sciences Promote and interconnect talented people and organization with Life Sciences ScienceOne is a dynamic and innovative organization that is at the forefront of scientific research and development. Our mission is to drive breakthroughs in technology, medicine, and engineering through collaboration and knowledge sharing. As ScienceLeadR.eu, we aim to connect scientists, researchers, and industry leaders to foster collaborations and accelerate the pace of scientific discovery. Join us to be part of a community that is shaping the future of science. santé, Health, biotech, healthtech, medtech, drugs, healthcare, health experts, … Type: | 17 | 7 |
 | Filière Intelligence Artificielle & Cancers Transform data into tangible innovations. The association "Artificial & amp; cancer intelligence" was created on August 3, 2021. It is the result of an unprecedented public partnership and brings together representatives of the National Cancer Institute, Health Data Hub, the Alliance for Research and Innovation of the Health Industries, France Biotech and nine of the largest health industrialists in oncology: AMGEN, AMGENCA Bristol-Myers Squibb, Janssen, MSD, Novartis, Pfizer, Pierre Fabre and Roche Diagnostic. Its ambition is to send, through all the data available in France, questions that bring value to patients and are transformed into tangible innovations in the field … Type: | 11 | 8 |
 | TECLIS Scientific Measuring Instruments and Services for Interface Science TECLIS Scientific is a French company specializes in measuring instruments and services to Study Foams, Emulsions, Surfaces & Interfaces. Over 25 years, the company has developed a renowned expertise in Interface Science and has become a key partner of Research. Today TECLIS Scientific provides a full range of solutions, from laboratory services to standardized or customized analytical Instruments: TRACKER is the only drop shape analysis-based technics that measures surface / interfacial tension, interfacial rheology and adsorption kinetics with a precise control of the drop / bubble volume, fully software driven. FOAMSCAN is the … | 1 | 19 |
 | Canceropole PACA The regional booster of anti-cancer research and innovations. A public interest group, Canceropôle brings together and serves the academic, scientific, medical and industrial community of Provence-Alpes-Côte d’Azur. Since 2003, it has acted at the heart of an ecosystem of excellence, to implement the national policy to combat cancer in a regional strategy for the benefit of patients. Our mission: to propel anti-cancer research and innovations, from fundamental discoveries to therapeutic applications. Listening to needs, we lead, support and accompany researchers and teams in different disciplines to accelerate progress towards the therapies of tomorrow. We promote the maturation and transfer of … Type: | 31 | 7 |
 | III-V Lab III-V Lab is a private R&D organisation jointly established by Nokia, Thales and the CEA under the French “Economic Interest Grouping” (GIE) status. III-V Lab concentrates in a single entity the most advanced industrial research capabilities in the field of III-V semiconductors in Europe. Such structure has enabled the rapid development of a common platform for dual use opto- and micro-electronic technology; it has been considered that both partners have brought balanced efforts, skills, equipment and background IPs, so that the costs of this common laboratory may be equally shared. III-V lab offers pre-commercial and customized production of III-V components … Type: | 5 | 53 |
 | Nanobiotix Building new therapies atom by atom. Incorporated in 2003, Nanobiotix is a leading, late clinical-stage nanotherapeutics company pioneering new approaches to significantly improve patient outcomes for millions around the world by building new therapies atom by atom. The Nanobiotix philosophy is one rooted in designing pioneer physical-based approaches to bring highly effective and generalized solutions to address high unmet medical needs and challenges. The Nanobiotix global development strategy seeks to address the largest market in oncology—patients who receive radiotherapy as part of their treatment—with NBTXR3 (JNJ-1900). As the first product candidate from the company’s nanoradioenhancer platform, NBTXR3 aims to increase … Type: | 15 | 145 |
 | Just - Evotec Biologics Designing and applying innovative technologies to dramatically expand global access to biotherapeutics. Just – Evotec Biologics, wholly owned by Evotec SE, is a first-to-industry biologics platform that leverages AI/ML technologies and world-leading molecular design, cell line development, process intensification and continuous manufacturing strategies to advance biotherapeutics from discovery through clinical stages to commercial launch. The Just – Evotec Biologics team combines deep industry experience in the fields of data, protein, process, and manufacturing sciences including automation with highly integrated and flexible capabilities to break through the scientific and economic barriers associated with the development of protein therapeutics. Our focus is … Type: | 6 | 603 |
 | Cofactor Genomics The Leaders in RNA Cofactor Genomics’s mission is to create diagnostics that have the ability to predict the patients that can benefit from immunotherapies. Using more insightful multidimensional biomarkers created with RNA and machine learning, Cofactor’s diagnostics offer greater predictive power than any current test. Instead of searching for isolated, single-analyte biomarkers or DNA mutations, Cofactor’s products create multidimensional biomarkers that better capture the complex immune response at the site of a tumor. Cofactor Genomics empowers clinicians to be better informed while making treatment decisions to improve patient outcomes. RNA, RNA-seq, NGS, Bioinformatics, and Diagnostics Type: | 3 | 11 |
 | Inmedical Therapeutics Innovation in medical needs. Inmedical Therapeutics es un fabricante de productos médicos y soluciones en formato hidrogel ubicado en Vitoria. Biotecnología, Endoscopia, Farmacéutica, and Producto Médico Type: | 0 | N/A |
 | Bioprocesia Proteína sostenible para alimentar al mundo 🌎 Circular feed for the world 🌎 We offer sustainable and customizable protein to the animal feed market Biotecnología, Bioprocesos, Biomasa, Proteína, Alimentación animal, Hipoalergénico, Adaptable, Customizable, Circular economy, Economía circular, Biotech, Fermentación, Fermentation, Bioprocess, Biomass, Animal feeding, Protein, Alternative protein, and Proteína alternativa Type: | 0 | 4 |
 | Isomab Ltd IsomAb is taking a different approach to identify, evaluate and develop isoform specific antibodies to treat disease where patients currently have limited or no treatment options. IsomAb is developing isoform specific antibodies and it has identified, using a combined bioinformatics/knowledge-based platform approach, ISM-001 which specifically inhibits the VEGF-A165b isoform of Vascular Endothelial Growth Factor-A (VEGF-A); based on 20 years of research by our two Founders, the evidence shows reducing serum levels of VEGF-A165b is key to ensuring new blood vessel formation in patients with ischemic disease. Type: | 0 | 14 |
 | Shuimu BioSciences Cryo-EM & AI Powered Drug Discovery Powerhouse. Shuimu is a rapidly evolving global cryo-EM & AI platform for early drug discovery, founded in 2017 and headquartered in Beijing, China. Shuimu drives innovation to accelerate the development of innovative drugs. Shuimu leverages the power of cutting-edge cryo-EM & AI technology to help its partners gain key structural insights into the target proteins and complexes. The team consists of top talents with global backgrounds in the field of structural biology, machine learning, protein science, and drug chemistry. Learn more about Shuimu and check out its cryo-EM precision imaging platform by visiting shuimubio.com … Type: | 0 | 24 |
 | Mosanna Therapeutics A Swiss Biotech company with a commitment to improving patient outcomes and quality of life in high unmet need diseases Mosanna is a Swiss Biotech company based in Basel with a commitment to improving patient outcomes and quality of life in high unmet need diseases, applying a precision medicine approach. We carefully select innovative medicines for further development using the best contract research organisations in the specific specialised field. Our first goal is to bring an effective and well tolerated medicinal nasal spray to Metabolic Obstructive Sleep Apnea patients. Type: | 0 | 7 |
 | PENTABIOL Animal Health We develop innovative products for feeding animals for human consumption, naturally improving their digestive function, defences and productivity. Thus, we also improve our diet and our quality of life. biotenología, animal, alimentación, and piensos Type: | 0 | 8 |
 | ASTRA Therapeutics Precision Drugs against Eucaryotic Pathogens ASTRA Therapeutics is a Drug Discovery company with a mission to design and develop novel, precision engineered drugs against a whole range of Eukaryotic Pathogens. Type: | 1 | 4 |
 | Gedea Biotech AB Developing antibiotic free treatment for vaginal infections Gedea Biotech develops pHyph to treat and prevent recurrence of bacterial vaginosis. Bacterial vaginosis (BV) is a very common condition with a prevalence of 10-30% for women of childbearing age. The symptoms can be very disturbing and include an often profuse thin, white, “fishy” smelling vaginal discharge. Standard treatment consists of antimicrobials, but recurrence rate is 15–30 % within 3 months. pHyph will treat the infection and prevent recurrence without the use of antmicrobials. Antimicrobial resistance is one of the World Health Organisation’s top ten threats to global health and research into novel … | 0 | 15 |
 | Invitris A startup using Synthetic Biology to innovate the way we develop entirely novel classes of protein-based drugs. Our patent-pending biotech platform, Phactory, makes designing synthetic proteins 10,000x more effiicent and reduces the material costs by 100x. We are leveraging Phactory to develop the newest classes of protein-based drugs, such as the next generation of antibiotics. Type: | 1 | 18 |
 | Beckley Psytech Pioneering the next generation of mental health treatments. Beckley Psytech Ltd is a private, independent biopharmaceutical company developing effective, rapid-acting and accessible medicines for people living with mental health conditions. Type: | 6 | 67 |
 | Ochre Bio Ochre Bio is a biotechnology company developing RNA therapies for chronic liver diseases. Using a combination of genomic deep phenotyping, precision RNA medicine, and testing in live human donor livers, Ochre is developing therapies for important liver health challenges, from increasing donor liver supply to reducing cirrhosis complications. To learn more, please visit www.ochre-bio.com. | 16 | 68 |
 | contextflow Comprehensive computer-aided detection software for lung cancer, ILD & COPD contextflow is your comprehensive solution for all things chest CT: lung cancer, ILD and COPD. Our computer-aided detection system ADVANCE Chest CT offers lung nodule detection & tracking of changes over time, quantitative and qualitative analysis of 8 key image patterns, and 3D image search for 19 image patterns. By integrating new technology from partner RevealDx, nodules can be further characterized, detecting lung cancer earlier and reducing costs (JACR 9/22). contextflow ADVANCE Chest CT includes a TIMELINE feature that even quantifies and visualizes nodules over time, allowing physicians to follow … Type: | 12 | 39 |
 | Cellestia Biotech Cellestia Biotech is pioneering innovative therapeutics based on novel modes of action to treat autoimmune diseases and multi-drug resistant cancers. Our clinical stage drug candidate, CB-103, has demonstrated both safety and biological activity in humans. Along with ongoing Phase 2 IITs for multi-drug resistant cancers, CB-103 is also poised to enter a Proof-of-Concept clinical study for graft-versus-host disease (GvHD) Biopharma, Oncology, Precision Medicine, Small Molecules, Targeted Therapy, Biotech, Cancer Therapy, Transcription Factors, Autoimmune Disorders, and Inflammatory Disorders Type: | 3 | 13 |
 | PinPoint Data Science Early cancer detection and healthcare system optimisation. PinPoint Data Science is a company formed around a team of world class data scientists who have developed a machine learning blood test that helps doctors triage patients by their risk of cancer: The PinPoint Test. Our ambition is to distill the vast and ever-increasing complexity of medical data into simple tools enabling clinicians to make better choices for their patients. Datascience, Cancer, Machine Learning, Artificial Intelligence, Diagnostics, Statistical Modelling, Clinical Support, and Cancer detection Type: | 3 | 13 |
 | Reliefband Technologies LLC The Anti-Nausea Wristband helping you overcome life's uncomfortable moments. Reliefband® is a world leader in neuromodulation creating the first FDA-cleared, clinically proven wearable device that treats nausea and vomiting associated with sea sickness, motion sickness, migraines, anxiety, and more. Worn on the wrist, Reliefband's patented technology stimulates a nerve that sends a message to the brain to "turn off" nausea, providing quick and effective relief without any unwanted side effects. Type: | 1 | 9 |
 | TreeFrog Therapeutics Cell Therapy for All TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients. TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality. Bringing together over 150 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M in 2021 to advance its pipeline of stem cell-based therapies in the field of regenerative medicine with the lead program in Parkinson's Disease. In 2022, the company opened a … Tags: FrenchTech120 FrenchTech2030 Type: | 49 | 174 |
 | YSOPIA Bioscience Leading biotech in the development of innovative microbiome-based biotherapies YSOPIA Bioscience is a clinical-stage biotech company developing cutting-edge biotherapies based on the gut microbiome. Our goal is to bring safe & efficient solutions to patients with high unmet medical needs. Microbiome, Obesity, Gut modulator, Cardiometabolism, Cardiometabolic diseases, Microbiota, and Gut microbiota Type: | 4 | 3 |
 | GATACA SYSTEMS Gataca Systems builds and integrates modular systems to perform the most demanding imaging and photo-manipulation techniques. Thus, we can integrate all the following techniques on new and existing microscope : Ring TIRF, FRAP, Photo-activation, Photo-ablation, Micropatterning, Single Molecule Super-Resolution, Live Confocal Super-Resolution, SPIM, Multichannel Detection (up to 4 channels), triple output high-power laser launches. All combinations can be done in a simultaneous manner. For more info : info@gataca-systems.fr www.gataca-systems.com spinning disk, TIRF microscopy, super resolution microscopy, FRAP microscopy, metamorph software, and Scientific cameras Type: | 0 | 7 |
 | Okomera Automated 3D organoid screening technology We integrate standard assays on chip (eg. CRISPR, T-cell, cytotoxicity) to accelerate drug discovery from target to validation, and advance preclinical predictivity Type: | 35 | 28 |
 | phagos Unleash Bacteriophage Potential We founded Phagos out of a common ideal: to use entrepreneurship as a force for positive change. Antibiotic resistance is an urgent and unaddressed global challenge that was declared a top 10 threat to humanity by the World Health Organisation. Experts project that this 'silent pandemic' could kill 10 million people per year by 2050. At Phagos, we're dedicated to finding a solution. Our approach is evolutionary—we harness the natural predator of bacteria, the bacteriophage, to cure these life-threatening infectious diseases. Bacteriophages can become an efficient and sustainable alternative to antibiotics. But this is just a fraction … Type: | 14 | 31 |
 | Rime Bioinformatics Making high performance bioinformatics accessible. Rime Bioinformatics is a research and development biotechnology company with a focus on bioinformatics. We develop services to speed up medical, agronomic and veterinary research. Our technologies grant in-depth view of bacterial and bacteriophage genomes, which is an essential prerequisite in the R&D process that leads a phage to market. We work hard to make high-performance bioinformatics accessible and promote a safe use of phage therapy for the patients and the environment ! Bioinformatics, Phage, Bacteriophage, Genomics, Bacteria, Phage Therapy, and metagenomics Type: | 2 | 5 |
 | PEP-Therapy Innovative peptides as targeted therapies for oncology PEP-Therapy is a clinical-stage biotechnology company developing first-in-class peptides as targeted therapies in oncology. PEP-010, first drug candidate, is a pro-apoptotic agent which has demonstrated anti-tumor efficacy in a number of pre-clinical models and a good safety profile. PEP-010 is currently evaluated in a Phase Ia/b clinical trial in patients with recurrent and/or metastatic solid tumors. PEP-Therapy was founded in 2014 and builds on research results from Institut Curie and Sorbonne University. The company is backed by international investors. cell penetrating peptide, protein-protein interaction, targeted therapies, oncology, clinical trial, and cancer Type: | 7 | 15 |
 | Microphyt Fostering a Blue Future ! Created in 2007 near Montpellier-France, Microphyt develops and markets unique microalgae-based bioactives using breakthrough technologies and processes. Developed over 10 years, and endorsed by key customers, partners and investors, these bioactives are addressing the nutraceutical & cosmetic industry sectors. photobioreactor, microalgae, nutrition, biotechnology, Blue Future, nutraceuticals, Made in France, Cosmetics, innovation, better living, patented technology, natural ingredients, and bioactive compounds Type: | 30 | 63 |
 | GenSight Biologics Applying pathbreaking science to transform the lives of patients with severe retinal neurodegenerative diseases GenSight Biologics is a clinical-stage biotechnology company discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system. GenSight Biologics’ pipeline leverages two core technology platforms, the Mitochondrial Targeting Sequence (MTS) and optogenetics for retinitis pigmentosa, to help preserve or restore vision in patients suffering from severe degenerative retinal diseases. GenSight Biologics’ lead product candidate, GS010, is in Phase III trials in Leber’s Hereditary Optic Neuropathy (LHON), a rare mitochondrial disease that leads to irreversible low vision and legal blindness in … Type: | 16 | 36 |
 | Affilogic Discovering and developing Nanofitins® through collaboration with worldwide pharma industry leaders Affilogic is a private biotech company specialised in discovering and developing Nanofitins® through early-stage collaborations with worldwide industry leaders in the pharmaceutical sector. These affinity proteins are potent antibody-mimetics, exhibiting a high affinity and specificity for capture, targeting and interacting with biomolecules. Each Nanofitin® is 20 times smaller than an antibody (7 kDa) and demonstrates hyper stability. Nanofitins are easily combined with each other, antibodies and other biomolecules by simple, rapid and proven methods to design an ideal targeted molecule. Affilogic has designed Nanofitins® against 60+ targets to date, … Type: | 4 | 38 |
 | ONLYNNOV Insurance broker for innovative companies : "we insure Frenchtech Worlwide" Insurance broker specializing in Innovative Compagnies risk management and insurance. We created a range of insurance products specificaly for your univers : - onlyNUM for software editors, cloud provider, digital services providers and web economy - onlyMED for Medical industries, life sciences, Medtech and devices, Biotech, Pharmaceuticals - onlyIOT for the Internet of Things, Mecatronics and Robotics Assurance des entreprises innovantes, Biotech, Medtech, Dispositifs Médicaux, Pharma, Numérique, Web, Cloud, Editeurs de Logicels, ESN SSII, objets connectés, Robotique, Robots, Mécatronique, Véhicules autonomes, Nouvelles mobilités, RC promoteur de recherche biomédicale, Responsabilité des … Type: | 27 | 11 |
 | GOSHABA Make Recruiting Fun, Fast and Fair! Goshaba makes recruitment more reliable, fun and fair (*Equitable). Goshaba was created in 2014 by Djamil and Minh two champions of the video game industry and Camille, researcher and world expert in neuroscience. Combining video games, data and neurosciences, Goshaba allows recruitment based on skills that really respect the candidates via a single candidate experience and the opportunity to obtain an interview whatever their age, social origin, gender, training, etc. Goshaba was awarded in the World Innovation Competition, Digital Innovation Competition, Techinnov, Vivatech, EDF Energy Diversity Award, etc. And is today supported by 5 … Type: | 50 | 11 |
 | Green Spot Technologies Challenging the food waste paradigm to feed a better future ✨FoodTech 500 ✨Earthshot Prize ✨French Tech 2030 Green Spot Technologies (GST) is leveraging solid state fermentation and upcycling to reinvent food ingredient solutions. 1/ Ferment'Up cocoa ingredients alternative solution range of powders for reducing cost and environmental footprint at once 2/ Ferment'Up tomato to sauce manufacturer for decreasing cost and optimising texture in their recipe with 100% of the tomato The company was initially founded in New Zealand following the PhD thesis of Dr. Ninna Granucci. In 2018, after a successful fundraising round, the company relocated to France, where both … Tags: FrenchTech2030 Type: | 49 | 24 |
 | omicX Unleashing the value of big biodata omicX is a global benchmark in big biodata analytics. Powered by machine teaching, its unique dynamic analytics ecosystem deciphers and analyses life science data. Combining artificial and collective intelligence, omicX’s disruptive approach empowers life science practitioners to shorten and improve decision-making, in order to accelerate scientific breakthroughs and go to market strategies. Accessible via web app, omicX is recognized as the most insightful life science analytics platform by a community of more than one million high-level users every year. Bioinformatics, Computational biology, Biologial data analysis , and Big data Type: | 0 | 0 |
 | EikoSim Bridge the gap between test and simulation EikoSim is committed to help simulation teams to bridge the gap between test and model during the development phase in mechanical industries. EikoTwin users respond faster to program requests and reduce delivery time to the final customer. digital image correlation, validation, finite element analysis, identification, mechanics, testing, simulation, and VVUQ | 17 | 10 |
 | Institut de Myologie Innovate to heal Located in Paris in the heart of the largest European hospital center, the Pitié-Salpêtrière hospital, the Institut de Myologie was born in 1996 under the leadership of an association of patients and parents of patients, AFM-Telethon. Its objective: to promote the existence, recognition and development of myology, science and muscle medicine, as a full -fledged discipline. Whether healthy, sick, accident, sporting, aging ... Muscle, on which our activity and vital functions depends, has become a real model of innovation for scientific and medical research and a public health issue. The Institute of Myology coordinates, around the patient, … Type: | 17 | 138 |
 | InSiliBio We use innovating solutions to test molecules through original bioinformatic methods. Our proposed methods are fully eth InSiliBio is a revolutionary contract research organization (CRO). We use innovating solutions to test molecules through original bioinformatic methods. Within the perspective of developing novel products and formulations, cosmetic, pharmaceutic and food companies undertake long research (up to several years), with expensive investments. These experiments often provide only fragmented information. These trials are sometimes being conducted on living organisms (animals, human cell etc. ), which are increasingly questioned from an ethical standpoint. Our proposed methods are fully ethical, fast, reliable and cost-effective. Our … Type: | 19 | 7 |
 | Institut Imagine Institut Imagine, pour guérir les maladies génétiques. Institut Imagine for genetic disease is a French translational research institute which performs state-of-the-art research in order to better understand genetic diseases. The Institute brings together scientists and physicians around the patients in a unique, ultra-modern 19,000 sqm building located within Necker Children’s Hospital, Paris. The teams also benefit from cutting-edge technological platforms and clinical facilities providing methodological advice as well as huge and rationalized cohorts of patients. The objective is to foster translational research and accelerate the development of new therapeutic and diagnostic solutions for the ultimate benefit of the patients and … Type: | 57 | 453 |
 | Hybrigenics Services Expert in target deconvolution for drugs, protein-protein interactions and single-domain antibodies Who else knows your drug or protein better than you? Who else knows protein interactions better than us? Hybrigenics Services is a complete solution provider of cutting-edge technologies dedicated to the study of protein interactions and target identification for drugs. We are also proud to now offer a unique, proprietary nanobody selection service. We help researchers: - Understand proteins' functions through the elucidation of their interactions - Characterize precisely a known interaction (map critical domains or amino-acids...) - Identify the targets of small molecules of therapeutic interest - Predict … Type: | 8 | 34 |
 | SoLongevity SoLongevity. Lifescience for HealthyAging SoLongevity promotes healthy ageing. How? By developing treatments and products, validated through solid clinical studies that aim to preserve what the World Health Organization has defined “physiological reserve”, that is the individual “capital-longevity” with which we are born and which constitutes the potential for health and wellbeing for the years to come. Our solutions are intended to allow each person to reach and maintain their maximum potential, preventing the risk conditions related to aging diseases. “Pathological” ageing is a phenomenon that is not only multifactorial but also articulated in a different and specific way for each … Type: | 0 | 14 |
 | Cluster Campania Bioscience Campania Bioscience is the regional cluster operating in the filed of Life Sciences Campania Bioscience is a regional cluster gathering together competences and facilities in the fields of Health, Biotech and Agro-food with the aim of valorizing the partners expertise in terms of value chain. The cluster is composed of 7 research entities, 51 companies and 2 Technology Transfer agencies. Networking and knowledge transfer are considered key assets to leverage competitiveness, entrepreneurship and innovativeness. The Cluster operates within: CEBR, European Biotechnology Network; ALISEI - Italian cluster on life sciences. Beneficiary of INNOSUP 2015-1, for the provision of advanced support to … Type: | 2 | 6 |
 | IntegraGen IntegraGen is an OncoDNA group company specializing in the genomics of cancer and rare genetic diseases. Backed by highly competent and qualified teams, IntegraGen is a leading player in DNA sequencing services and genomic data interpretation software. The company runs one of the largest NGS labs in France and operates for research institutes of excellence. As part of OncoDNA group, IntegraGen leverages the power of next generation sequencing with the mission of delivering the promise of precision medicine to patients. IntegraGen has about 50 employees and generated €9 million of revenue in 2020. Based in France, IntegraGen is also present … Type: | 6 | 51 |
 | CRF Assurances - A howden company Le plus grand risque, c'est de penser que vous ne risquez rien. Created in 1999, CRF Assurances is a French Insurance Broker, specialized in Financial Lines risks. CRF Assurances is offering a large scale of insurance products which are customized and tailored made to suit profiles and activities for : - Startup from seed-stage to IPO quotation (Digital, Life Science and E-Health) - Financial Institutions (VC, Asset Management, Fintech) - Incubators CRF Assurances is notably specialized in General Liability, Professional Liability, E&O, D&O, Cyber, EPL and Property damages Fusions & Acquisitions, Responsabilité des Dirigeants, Homme-clé, Responsabilité Professionnelle, Kidnapping, Fraude, CyberRisques, … Type: | 53 | 25 |
 | Fondation Neurodis Together, let's help research on brain diseases! The Neurodis Foundation supports in Rhône-Alpes & amp; Auvergne a network of 800 researchers and clinicians to develop basic and clinical research projects on the brain. The goal is to provide new neuroscience research solutions, so that patients and their loved ones benefit from medical advances as quickly as possible. Type: | 15 | 4 |
 | Fondation ARC pour la recherche sur le cancer Our conviction: research will defeat cancer. Our goal: to cure cancer, all cancers! The ARC Foundation teams share a common conviction: only research will defeat cancer! This is why we have put research at the heart of our mission, research on cancer and for individuals, dynamic and positive research, accessible to the greatest number. Even if the challenges remain numerous ... We act on a daily basis to release the potential of French research in oncology: • by drawing its strategic orientations, • By supporting the most innovative initiatives today for tomorrow, • by accelerating the most promising projects, • … Type: | 28 | 80 |
 | Marginum Marginum is a university-based medical technology startup developing fluorescence-based tissue detection systems. The Company’s data-driven solutions enable safe and efficient monitoring of tumor tissues during cancer surgery without compromising pre-existent surgical workflows. The products are derived from state-of-the-art research to improve surgical performance and cost-effectiveness. Marginum’s multidisciplinary team works in close cooperation with academic, clinical and industrial experts to ensure its technological solutions’ seamless clinical compatibility. Type: | 1 | 9 |
 | ILC Therapeutics ILC Therapeutics is a specialist UK-based developer of hybrid interferons, a new engineered drug class with improved therapeutic profiles, enabling broad applications across multiple indications. Hybrid interferons combine favourable attributes of specific natural interferon sub-types to produce novel drug candidates designed to deliver reduced toxicity and improved efficacy. ILC Therapeutic’s platform approach has produced two first-in-class lead candidates, AlfacyteTM and DermacyteTM focused on antiviral and dermatological indications respectively, which are progressing towards the clinic. Type: | 0 | 7 |
 | Enzymatica AB Enzymatica is a life science company whose business concept is to offer effective aid against some of our most common diseases where viruses or bacteria play a decisive role. Over a short period the company has developed a unique oral spray for common colds, ColdZyme® and launched it on four markets. The product became the leading article for common cold in Swedish pharmacies during winter 2014-2015. For product inf, please visit at www.coldzyme.co.uk. The development program includes medical devices in upper respiratory infections and oral health, and veterinary products. Cold and Flu, Enzyme (trypsin), and Barrier technology Type: | 0 | 25 |
 | Registrar Corp Registrar Corp is your trusted partner helping you navigate global regulatory requirements. Registrar Corp is your trusted partner helping you navigate global regulatory requirements with expert services, innovative software solutions and comprehensive online compliance training to minimize business risk and avoid costly disruptions. ISO 27001 certified and serving over 30,000 clients in over 200 countries across the food and beverage, drug, cosmetics, and medical device industries, Registrar is the most trusted leader in the industry. We provide expert assistance in 19 regional offices globally, 24 hours per day, 7 days per week. U.S. FDA Food, Beverage, and Dietary Supplement Regulations, … Type: | 7 | 273 |
 | TriNetX TriNetX is a global network of healthcare organizations and life sciences companies driving real-world research to accelerate the development of new therapies. Through its self-service, HIPAA, GDPR, and LGPD-compliant platform of federated EHR, datasets, and consulting partnerships, TriNetX puts the power of real-world data into the hands of its worldwide community to improve protocol design, streamline trial operations, refine safety signals, and enrich real-world evidence generation. Real World Data Network, Collaborative Research, Clinical Trial Design, Patient Recruitment, Federated Network, Principal Investigator Recruitment, EMR, Real World Evidence, Pharmacovigilance, Protocol Design, Clinical Trial Optimization, Site Selection, and Investigator Initiated Studies Type: | 8 | 296 |
 | Rare Disease Ghana Initiative The National Alliance Non-Governmental Organisation leading Advocacy and Coordinating Care for Rare Diseases in Ghana. Rare Disease Ghana Initiative (RDGI) is a nonprofit organisation in Ghana made up of multidisciplinary team of professionals, patients and their caregivers whose vision is to be the the lead and the voice coordinating rare disease care in Ghana. RDGI has established this multidisciplinary team to develop, seek wide endorsement and to advocate for the implementation of a plan to support research, education, service development, promote awareness of rare diseases and support for affected individuals and their carers. RDGI has the mission to improve the … Type: | 3 | 20 |
 | University of Colorado BioFrontiers Institute Undaunted exploration of the greatest challenges in human health and welfare At the University of Colorado BioFrontiers Institute, researchers from the life sciences, physical sciences, computer science and engineering are working together to uncover new knowledge at the frontiers of science and partnering with industry to transform their discoveries into new tools. The BioFrontiers Institute is uniquely defined both by our excellent faculty, research, and leadership and by the scientific and geographical ecosystem that empowers our work. BioFrontiers has a unique “frontier” culture that allows our researchers to explore new areas of bioscience by leveraging the resources and talents across … Type: | 31 | 32 |
 | Drugs for Neglected Diseases initiative (DNDi) International non-profit developing safe, effective, and affordable treatments for the most neglected patients. The Drugs for Neglected Diseases initiative (DNDi) is an international, not-for-profit research and development organization. We discover, develop, and deliver treatments for neglected patients around the world. Our treatments are affordable and patient-friendly – and have already saved millions of lives. We are researching new treatments for people living with Chagas disease, sleeping sickness (human African trypanosomiasis), leishmaniasis, filarial infections, mycetoma, paediatric HIV, hepatitis C, and dengue. Together with our partners, we are working on over 40 projects, including more than 20 new chemical entities. We are … Type: | 20 | 422 |
 | Max Perutz Labs Vienna Research institute dedicated to a mechanistic understanding of fundamental biomedical processes. The Max Perutz Labs are a joint venture between the University of Vienna and the Medical University of Vienna that builds on the unique opportunities that arise from being embedded in the Vienna BioCenter Campus while having one of the largest hospitals in Europe, the Vienna General Hospital, on our doorstep. In visualizing haemoglobin, Max Perutz paved the way towards the era of precision medicine. To realize its full potential, precision medicine necessitates a molecular mechanistic approach. Research at the Max Perutz Labs is curiosity-driven and spans the fields … Type: | 5 | 177 |
 | Takodana Portugal Takodana Portugal is a medical cannabis company, based in Portugal, licensed by the portuguese regulator - INFARMED. Takodana Portugal is a licensed medical cannabis company based in Portugal. We specialize in cultivating premium-quality cannabis, leveraging cutting-edge technology and the expertise of a dedicated, experienced team to ensure the highest standards in every step of the process. Type: | 23 | 7 |
 | EyeWire EyeWire is a game to map the brain in collab with Seung Lab at Princeton. Anyone can play and you need no scientific background — 200,000 people from 145 countries already do. Together we are mapping the 3D structure of neurons; advancing our quest to understand ourselves. By joining EyeWire, you can help map the connectome, starting with connections between retinal neurons. EyeWire gameplay advances neuroscience by helping researchers discover how neurons connect and network to process information. You also help develop advanced artificial intelligence and computational technologies for mapping the connectome. neuroscience, gaming, and research Type: | 5 | 6 |
 | Oxford Nanopore Technologies Our goal is to enable the analysis of anything, by anyone, anywhere. Our goal is to enable the analysis of anything, anywhere, by anyone. We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data. We are aiming to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society. Our devices offer real-time analysis, … Type: | 8 | 1,383 |
 | ILIFE CONSULTING A reliable clinical development partner CRO, synchronizing endpoints with funding milestones, ensuring impactful trials 🤝ILife Consulting is an entrepreneurial CRO partner specializing in early-phase clinical development. With over 25 years of experience and more than 30 clinical trials supervised, our team of experts transforms clinical data into value-creating assets for your company. We support over 20 active clients, including leading biotechs such as ImCheck, Peptinov, Smart Immune, and Brenus Pharma, as well as prestigious clinical sites like Gustave Roussy. Our expertise in First-in-Human and Proof-of-Concept studies enables us to generate critical data that enhance the value of your assets and … Type: | 4 | 24 |
Startup